OPDUALAG (NIVOLUMAB AND RELATLIMAB-RMBW) Trademark

Trademark Overview


On Friday, April 1, 2022, a trademark application was filed for OPDUALAG (NIVOLUMAB AND RELATLIMAB-RMBW) with the United States Patent and Trademark Office. The USPTO has given the OPDUALAG (NIVOLUMAB AND RELATLIMAB-RMBW) trademark a serial number of 97342302. The federal status of this trademark filing is REGISTERED as of Tuesday, August 8, 2023. This trademark is owned by Bristol-Myers Squibb Company. The OPDUALAG (NIVOLUMAB AND RELATLIMAB-RMBW) trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use comprising monoclonal antibodies for the treatment and prevention of cancer
opdualag (nivolumab and relatlimab-rmbw)

General Information


Serial Number97342302
Word MarkOPDUALAG (NIVOLUMAB AND RELATLIMAB-RMBW)
Filing DateFriday, April 1, 2022
Status700 - REGISTERED
Status DateTuesday, August 8, 2023
Registration Number7130293
Registration DateTuesday, August 8, 2023
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 23, 2023

Trademark Statements


Description of MarkThe mark consists of the term "OPDUALAG" in blue with a curved line over it in light blue and yellow and the term "(NIVOLUMAB AND RELATLIMAB-RMBW)" in blue below it.
Goods and ServicesPharmaceutical preparations for human use comprising monoclonal antibodies for the treatment and prevention of cancer
Indication of Colors claimedThe color(s) Blue, Light Blue and Yellow is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"NIVOLUMAB AND RELATLIMAB-RMBW"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 6, 2022
Primary Code005
First Use Anywhere DateTuesday, March 22, 2022
First Use In Commerce DateTuesday, March 22, 2022

Trademark Owner History


Party NameBristol-Myers Squibb Company
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08543

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08543

Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10016

Trademark Events


Event DateEvent Description
Tuesday, August 8, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 8, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, August 2, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 2, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 2, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 23, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 23, 2023PUBLISHED FOR OPPOSITION
Wednesday, May 3, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 17, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 17, 2023EXAMINER'S AMENDMENT ENTERED
Monday, April 17, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, April 17, 2023EXAMINERS AMENDMENT E-MAILED
Monday, April 17, 2023EXAMINERS AMENDMENT -WRITTEN
Friday, April 14, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 13, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 13, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 14, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 14, 2022NON-FINAL ACTION E-MAILED
Friday, October 14, 2022NON-FINAL ACTION WRITTEN
Friday, September 30, 2022ASSIGNED TO EXAMINER
Thursday, April 7, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, April 6, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 5, 2022NEW APPLICATION ENTERED